Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urinary polyamine levels in human cancer.

A Lipton, L M Sheehan, G F Kessler

    Cancer
    |February 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Urinary polyamine levels, including putrescine, spermidine, and spermine, were elevated in most cancer patients. These biomarkers may indicate the presence of localized or metastatic malignant tumors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    RANKL enhances the effect of an antagonist of inhibitor of apoptosis proteins (cIAPs) in RANK-positive breast cancer cells.

    Journal of bone oncology·2016
    Same author

    Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics.

    European journal of cancer (Oxford, England : 1990)·2015
    Same author

    Elevation in multiple serum inflammatory biomarkers predicts survival of pancreatic cancer patients with inoperable disease.

    Journal of gastrointestinal cancer·2014
    Same author

    Skeletal-related events and clinical outcomes in patients with bone metastases and normal levels of osteolysis: exploratory analyses.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2012
    Same author

    Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?

    Cancer treatment reviews·2012
    Same author

    Transforming growth-factor-alpha and factor-beta(1) levels in plasma and effusions from patients with cancer or hematologic malignancies.

    International journal of oncology·2011
    Same journal

    Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study.

    Cancer·2026
    Same journal

    Bendamustine in indolent lymphoma: Letting the dust settle down.

    Cancer·2026
    Same journal

    Top advances of the year: Bispecific antibodies in early lines of therapy in multiple myeloma.

    Cancer·2026
    Same journal

    Direct oral anticoagulants and warfarin in atrial fibrillation patients with cancer by anticoagulation quality.

    Cancer·2026
    Same journal

    Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

    Cancer·2026
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    See all related articles

    Area of Science:

    • Biochemistry
    • Oncology
    • Urology

    Background:

    • Polyamines (putrescine, spermidine, spermine) are essential for cell growth and proliferation.
    • Altered polyamine metabolism is frequently observed in various cancers.
    • Urinary polyamine levels may serve as potential non-invasive biomarkers for cancer detection.

    Purpose of the Study:

    • To establish normal urinary polyamine levels in healthy individuals.
    • To investigate the correlation between elevated urinary polyamine levels and the presence of malignant tumors.
    • To assess the diagnostic potential of urinary polyamines in differentiating cancer from benign conditions.

    Main Methods:

    • Quantification of urinary polyamines (putrescine, spermidine, spermine) using high-voltage electrophoresis.

    Related Experiment Videos

  • Analysis of 24-hour urine samples from 42 healthy volunteers to establish reference ranges.
  • Comparison of polyamine levels in patients with localized and metastatic cancers, as well as benign conditions.

    • Main Results:

    • Elevated urinary polyamine levels were detected in 38 out of 56 patients with metastatic cancer.
    • Approximately two-thirds of patients with metastatic adenocarcinoma, squamous cell carcinoma, or metastatic disease to the liver, lungs, or bones exhibited elevated levels.
    • All 6 patients with localized malignant tumors showed elevated urinary polyamine levels. Elevations were also observed in patients with benign prostatic hypertrophy and bronchial adenoma.

    Conclusions:

    • Elevated urinary polyamine levels are frequently associated with both localized and metastatic malignant tumors.
    • Urinary polyamine analysis shows potential as a biomarker for cancer detection, although elevations can also occur in certain benign conditions.
    • Further research is warranted to refine the diagnostic utility of urinary polyamines in clinical oncology.